Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1966 1
1967 1
1968 4
1969 19
1970 24
1971 24
1972 36
1973 17
1974 31
1975 30
1976 26
1977 30
1978 29
1979 27
1980 34
1981 30
1982 46
1983 42
1984 41
1985 33
1986 40
1987 19
1988 36
1989 29
1990 28
1991 24
1992 30
1993 22
1994 28
1995 30
1996 31
1997 35
1998 24
1999 24
2000 32
2001 28
2002 32
2003 29
2004 34
2005 23
2006 24
2007 36
2008 27
2009 23
2010 29
2011 37
2012 31
2013 30
2014 24
2015 37
2016 29
2017 43
2018 37
2019 34
2020 42
2021 31
2022 19
2023 35
2024 30
2025 38
2026 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,677 results

Results by year

Filters applied: . Clear all
Page 1
Insomnia: Pharmacologic Therapy.
Matheson E, Hainer BL. Matheson E, et al. Am Fam Physician. 2017 Jul 1;96(1):29-35. Am Fam Physician. 2017. PMID: 28671376 Free article. Review.
Understanding the risks and benefits of insomnia medications is critical. Controlled-release melatonin and doxepin are recommended as first-line agents in older adults; the so-called z-drugs (zolpidem, eszopiclone, and zaleplon) should be reserved for use if the first-line …
Understanding the risks and benefits of insomnia medications is critical. Controlled-release melatonin and doxepin are recommended as …
Dysmorphophobia.
Jenike MA. Jenike MA. Br J Psychiatry. 1985 Mar;146:326. doi: 10.1192/bjp.146.3.326a. Br J Psychiatry. 1985. PMID: 3986443 No abstract available.
Trazodone-induced mania.
Lennhoff M. Lennhoff M. J Clin Psychiatry. 1987 Oct;48(10):423-4. J Clin Psychiatry. 1987. PMID: 3667543 No abstract available.
Cimetidine-doxepin interaction.
Brown MA, Haight KR, McKay G. Brown MA, et al. J Clin Psychopharmacol. 1985 Aug;5(4):245-7. J Clin Psychopharmacol. 1985. PMID: 4019813 No abstract available.
Low-dose doxepin: in the treatment of insomnia.
Weber J, Siddiqui MA, Wagstaff AJ, McCormack PL. Weber J, et al. CNS Drugs. 2010 Aug;24(8):713-20. doi: 10.2165/11200810-000000000-00000. CNS Drugs. 2010. PMID: 20658801 Review.
Symptom control was maintained for up to 12 weeks of low-dose doxepin administration and there was no evidence of physical dependence or worsening insomnia after doxepin withdrawal. ...Oral, low-dose doxepin was generally well tolerated in clinical trials....
Symptom control was maintained for up to 12 weeks of low-dose doxepin administration and there was no evidence of physical dependence …
Low-dose doxepin (Silenor) for insomnia.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2010 Oct 4;52(1348):79-80. Med Lett Drugs Ther. 2010. PMID: 20885342 Review. No abstract available.
Bioequivalence: issues and options.
Midha KK, Rawson MJ, Hubbard JW. Midha KK, et al. J Pharmacokinet Biopharm. 1997 Dec;25(6):743-52. doi: 10.1023/a:1025785902230. J Pharmacokinet Biopharm. 1997. PMID: 9697081 Review. No abstract available.
Doxepin withdrawal mania.
Galynker II, Rosenthal RN, Perkel C, Shwartz A. Galynker II, et al. J Clin Psychiatry. 1995 Mar;56(3):122-3. J Clin Psychiatry. 1995. PMID: 7883732 No abstract available.
Doxepin for insomnia: a systematic review of randomized placebo-controlled trials.
Yeung WF, Chung KF, Yung KP, Ng TH. Yeung WF, et al. Sleep Med Rev. 2015 Feb;19:75-83. doi: 10.1016/j.smrv.2014.06.001. Epub 2014 Jun 19. Sleep Med Rev. 2015. PMID: 25047681
A total of nine randomized placebo-controlled trials were analyzed. Six studies were on doxepin 1-6 mg/d, two on doxepin 25-300 mg/d, and one on ramelteon 8 mg and doxepin 3 mg combined. ...There was no significant next-day residual effect with low-dose do …
A total of nine randomized placebo-controlled trials were analyzed. Six studies were on doxepin 1-6 mg/d, two on doxepin 25-30 …
Doxepin hydrochloride.
Hollister LE. Hollister LE. Ann Intern Med. 1974 Sep;81(3):360-3. doi: 10.7326/0003-4819-81-3-360. Ann Intern Med. 1974. PMID: 4604347 Clinical Trial. No abstract available.
1,677 results